content

T2 Biosystems T2SARS-CoV-2 Panel Detects Omicron Subvariants

T2 Biosystems, Inc, a leader in the rapid detection of sepsis-causing pathogens, announced that its T2SARS-CoV-2โ„ข Panel detects Omicron COVID-19 subvariants BA.1, BA.2, and...

Procaps Group Announces Capacity Expansion Plans in the United States with Construction of New Gummy Manufacturing Facility in Florida

Procaps Group, a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced a new capacity expansion plan in the United States and Colombia for its...

Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

Castor, a leading provider of decentralized and hybrid clinical trial solutions, announced the official launch of its CRO Partnership program. Designed to support clinical...

The leading supplier of injection vials Gerresheimer expands production in Wertheim

Gerresheimer is expanding its capacities for glass vials at the Wertheim site and at two further sites in China and the USA. The company...

Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

Cytiva, a global life sciences leader, and NecstGen, aim to accelerate the development of new cell and gene therapies globally via a strategic collaboration....

Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate

Valneva SE, a specialty vaccine company, announced the initiation of a Phase 3 trial in adolescents for its single-shot chikungunya vaccine candidate, VLA1553. Funded by...

Sputnik V vaccine granted full permanent approval in Russia

The Russian Direct Investment Fund (RDIF, Russiaโ€™s sovereign wealth fund) announces that the Russian Sputnik V vaccine against coronavirus has been granted full permanent...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read